Torrent Pharmaceuticals has announced that its Securities Transfer and Stakeholders Relationship Committee will convene on January 5, 2026, to evaluate and approve a proposal for the issuance of secured Non-Convertible Debentures. The issuance will be executed through a private placement basis, remaining within the limits authorized by the Board of Directors at their meeting on July 28, 2025.
Meeting for Debenture Issuance
A meeting of the Securities Transfer and Stakeholders Relationship Committee at Torrent Pharmaceuticals is scheduled for January 5, 2026. The primary agenda is to discuss and potentially approve the issuance of secured Non-Convertible Debentures (NCDs).
Private Placement Details
The company intends to issue these debentures through a private placement method. This proposal aligns with the directives approved by the Board of Directors during their meeting held on July 28, 2025, which authorized the issuance within specified limits.
Source: BSE
